Role of brentuximab vedotin in the treatment of relapsed or refractory Hodgkin lymphoma
Tanya Siddiqi, Sandra H Thomas, Robert Chen City of Hope, Department of Hematology and Hematopoietic Cell Transplantation, Duarte, CA, USA Abstract: Brentuximab vedotin (BV) is an antibody-drug conjugate that targets CD30-positive malignancies via an anti-CD30 monoclonal antibody linked to monomet...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2014-02-01
|
| Series: | Pharmacogenomics and Personalized Medicine |
| Online Access: | http://www.dovepress.com/role-of-brentuximab-vedotin-in-the-treatment-of-relapsed-or-refractory-a15883 |